High-end suppliers of chemical, biological reagents, pharmaceutical intermediates and APIs
Current Location:Home > API
More PEG Derivatives  |   Pharma Intermediates  |   API  |   Vaccine Excipients  |   Chemical Reagents  |  

API

Plerixafor

Plerixafor
User Evaluation Collection Products
Synonyms
1,4-Bis((1,4,8,11-tetraazacyclotetradecan-1-yl)methyl)benzene
Catalog ID
99759
CAS NO.
110078-46-1
Purity
98%
MDL Number
MFCD05662218
EINECS
Molecular formula
C28H54N8
Molecular weight
502.782
Huateng Pharmaceutical, a global supplier of pharmaceutical intermediates & chemical products & biological reagent & PEG derivatives, offers Plerixafor, CAS NO.110078-46-1 for your requirements of R&D, evaluation, pilots and commercial along with supportive technical package required for evaluation.

Application: Plerixafor, CAS NO.110078-46-1 is a hematopoietic stem cell (HSC) mobilizer that inhibits the CXCR4 chemokine receptor and blocks binding of its ligand, stromal cell-derived factor-1-α (SDF-1-α). This agent was approved on Dec. 15, 2008, as treatment in combination with granulocyte-colony stimulating factor (G-CSF) to mobilize HSCs to the peripheral blood for collection and subsequent autologous transplantation in patients with non-Hodgkin's lymphoma (NHL) and multiple myeloma (MM). Selective CXCR4 antagonist.

I want to comment